广发医药健康混合C(010111)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-40,369,901.40 |
602,007,057.20 |
660,123,372.43 |
-263,247,054.79 |
| 利息合计 |
490,614.17 |
1,187,961.09 |
731,627.41 |
1,210,812.20 |
| 其中:存款利息收入 |
490,614.17 |
807,508.90 |
351,175.22 |
1,210,812.20 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
380,452.19 |
380,452.19 |
- |
| 投资收益合计 |
-7,992,069.30 |
441,004,241.65 |
73,384,368.39 |
-425,743,794.94 |
| 其中:股票投资收益 |
-10,686,939.10 |
428,804,938.59 |
64,594,585.71 |
-448,604,665.79 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
-6,847.89 |
-1,605.86 |
232,282.17 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
2,694,869.80 |
12,206,150.95 |
8,791,388.54 |
22,628,588.68 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-34,043,691.09 |
157,825,709.18 |
585,170,953.12 |
160,947,504.74 |
| 其他收入 |
1,175,244.82 |
1,989,145.28 |
836,423.51 |
338,423.21 |
| 费用 |
15,444,966.89 |
36,783,890.38 |
16,680,764.49 |
35,011,689.12 |
| 管理人报酬 |
11,707,456.63 |
28,055,133.85 |
12,782,485.06 |
26,680,684.26 |
| 基金托管费 |
1,951,242.81 |
4,675,855.74 |
2,130,414.23 |
4,446,780.77 |
| 销售服务费 |
1,641,771.47 |
3,736,233.52 |
1,613,222.62 |
3,594,554.63 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
144,495.98 |
316,667.27 |
154,642.58 |
289,668.38 |
| 利润总额 |
-55,814,868.29 |
565,223,166.82 |
643,442,607.94 |
-298,258,743.91 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年